We read with significant concern the perspective by Dr Breslow1 on the 2013 American
College of Cardiology/American Heart Association Cholesterol and Risk Assessment …

Many voices in the public and the medical community argue strongly against the widespread
use of statins for the primary prevention of atherosclerotic cardiovascular disease. Critics …

Physicians (ACP) that recommend widespread use of cholesterollowering statins to prevent
cardiovascular disease in patients with type 2 diabetes mellitus signal a shift from current …

We read with interest the recent systematic review and meta-analysis by Dale et al 1
comparing higher versus lowerintensity therapy on liver and muscle safety and reporting on …

Charles Howard Chandler Professor of Internal Medicine, Director, Division of
Arteriosclerosis and Lipid Metabolism, Emory University School of Medicine, Atlanta …

Background—Although statins reduce the risk of cardiovascular events, concerns about
adverse effects may deter physicians from prescribing these agents. We performed a …

We agree that statins are effective for secondary prevention of cardiovascular events. But
data from the 2012 Cholesterol Treatment Trialists'(CTT) meta-analysis2 showed that 189 …

“The numbers of people who avoid heart attacks and strokes by taking statin therapy are
very much larger than the numbers who have side effects with it,” claims Rory Collins, lead …

The ongoing controversy over whether healthy people should take cholesterol-lowering
statin drugs to prevent heart disease has become intense, more so in the UK than in the …

More than 30 years of evidence show that statin (in particular high-intensity statin) therapy
reduces major vascular events in patients with atherosclerotic cardiovascular disease …